-

Global Reduced Fat Bakery Products (2020 to 2027) - Key Market Trends and Drivers - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Reduced Fat Bakery Products - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Reduced Fat Bakery Products estimated at US$25.2 Billion in the year 2020, is projected to reach a revised size of US$32.5 Billion by 2027, growing at a CAGR of 3.7% over the period 2020-2027.

The U.S. Market is Estimated at $6.8 Billion, While China is Forecast to Grow at 5.9% CAGR

The Reduced Fat Bakery Products market in the U.S. is estimated at US$6.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.5 Billion by the year 2027 trailing a CAGR of 5.9% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.2% and 2.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Select Competitors (Total 55 Featured):

  • Arla Foods Inc
  • Crowley Food LLC
  • Danone SA
  • Dean Foods
  • General Mills
  • Kellogg
  • Mondelez International
  • Nestle SA
  • PepsiCo Inc
  • Tesco
  • The Kraft Heinz Company

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 55

For more information about this report visit https://www.researchandmarkets.com/r/c5riaz

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Vertigo Drugs Market Outlook Report 2026-2034 - Landscape Shift Towards Targeted Drug Regimens Over Blanket Suppression, Emphasizing Early Rehab and Non-Sedating Prophylactics - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Vertigo Drugs Market Outlook 2026-2034: Market Share, and Growth Analysis" has been added to ResearchAndMarkets.com's offering. The Vertigo Drugs Market is projected to grow significantly, with a valuation of USD 1.66 billion in 2025 and targeted to reach USD 2.38 billion by 2034 at a CAGR of 3.9%. This market covers the pharmacologic management of various vestibular disorders within multiple medical settings, including ENT, neurology, and primary care. Core applic...

Trends Shaping the $5 Billion Spasticity Treatment Market, 2026-2034: Focus on Multimodal Care and Treatment Innovations - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Spasticity Treatment Market Outlook 2026-2034: Market Share, and Growth Analysis" has been added to ResearchAndMarkets.com's offering. The global Spasticity Treatment Market, valued at USD 5.02 billion in 2025, is set to expand at a CAGR of 5.5%, reaching USD 8.13 billion by 2034. This growth is driven by innovations in pharmacologic therapies, interventional procedures, and multimodal rehabilitative modalities designed to manage spasticity associated with various...

Intracranial Aneurysm Market and Competition Outlook 2026-2034: Market Share, Growth Analysis, Strategic Initiatives and Emerging Trends - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Intracranial Aneurysm Market Outlook 2026-2034: Market Share, and Growth Analysis" has been added to ResearchAndMarkets.com's offering. The Intracranial Aneurysm Market, valued at USD 1.79 billion in 2025, is forecasted to grow at a CAGR of 10% to reach USD 4.22 billion by 2034. Trends indicate enhanced demand for low-profile flow diverters, resheathable delivery systems, and AI-assisted aneurysm detection, propelled by the global incidence of subarachnoid hemorrha...
Back to Newsroom